People: Alkermes Plc (ALKS.O)
29 Jul 2016
Mr. James M. Frates is Chief Financial Officer, Senior Vice President of Alkermes Plc. Prior to assuming his current position, from May 2007 to September 16, 2011, Mr. Frates served as Senior Vice President and Chief Financial Officer of Alkermes, Inc. From June 1998 to May 2007, Mr. Frates served as Vice President, Chief Financial Officer and Treasurer of Alkermes, Inc. From June 1996 to June 1998, he was employed at Robertson, Stephens & Company, most recently as a Vice President in Investment Banking. Prior to that time he was employed at Morgan Stanley & Co. Mr. Frates serves on the Board of Directors of Sage Therapeutics, a publicly traded biotechnology company. Mr. Frates served on the board of directors of GPC Biotech AG, a biotechnology company, from June 2004 to 2009, and was a national director of the Association of Bioscience Financial Officers from 2004 to 2009. Mr. Frates is also a Trustee of St. Paul's School.
|Total Annual Compensation, USD||468,727|
|Restricted Stock Awards, USD||530,550|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||1,566,120|
|Fiscal Year Total, USD||2,565,400|